Genitourinary System Carcinoma — Trials

Genitourinary System Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

4,916 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,498
Recruiting: 782
Ph III recruiting: 85
Growth YoY: +17.8%
Industry share: 27%
Top sponsor: National Cancer Institute (NCI)
Termination share: 37.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (758)

clinicaltrialsPublishedShowing 51–85 of 85 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02031328	Two StereoTactic Ablative Adaptive Radiotherapy Treatments for Localized Prostate Cancer(2STAR)	unknown	Phase 1 / Phase 2	30	Sunnybrook Health Sciences CentreOTHER	1	Nov 24, 2020	clinicaltrials
NCT04486937	SC10914 Monotherapy for the mCRPC With g/s BRCA Mutation(mCRPC)	unknown	Phase 1 / Phase 2	90	Jiangxi Qingfeng Pharmaceutical Co. Ltd.INDUSTRY	0	Jul 27, 2020